FMR1 and fragile X syndrome: Recently, with the technology of the CRISPR-Cas9 system applied in vivo to laboratory mice, it has become possible to demonstrate that DNA methylation at the FMR1 gene causes the molecular and physiological phenotype of fragile-X syndrome [29].